Prognostic value of QT interval parameters in type 2 diabetes mellitus: Results of a long-term follow-up prospective study

Journal of Diabetes and its Complications

Volumn 17, Issue 4, 2003, Pages 169-178

  Cardoso, Claudia R L ^a,b   Salles, Gil F ^a   Deccache, Waldemar ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Mortality; QT dispersion; QT interval; Risk factors; Type 2 diabetes mellitus

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; ELECTROCARDIOGRAM; EVALUATION; FEMALE; FOLLOW UP; GENDER; HAZARD ASSESSMENT; HEART RATE; HEART REPOLARIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PARAMETER; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QT INTERVAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0042323288     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00206-4     Document Type: Article

References (47)

1. Arildsen H., May O., Christiansen E.H., Damsgaard E.M. Increased QT dispersion in patients with insulin-dependent diabetes mellitus. International Journal of Cardiology. 71:1999;235-242.
2. Bazzet H.D. An analysis of the time relations of electrocardiograms. Heart. 7:1920;353-370.
3. Bland J.M., Altman D.G. Statistical methods for assessing agreements between two methods of clinical measurement. Lancet. 1(8476):1986;307-310.
4. Boesrsma E., Pieper K.S., Steyerberg E.W., Wilcox R.G., Chang W.C., Lee K.L., Akkerhuis K.M., Harrington R.A., Deckers J.W., Armstrong P.W., Lincof A.M., Califf R.M., Topol E.J., Simoons M.L. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. for the PURSUIT Investigators Circulation. 101:2000;2257-2267.
5. Brendorp B., Elming H., Jun L., Kober L., Malik M., Jensen G.B., Torp-Pedersen C. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. for the Diamond Study Group Circulation. 103:2001;831-835.
6. Brooksby P., Batin P.D., Nolan J., Lindsay S.J., Andrews R., Mullen M., Baig W., Flapan A.D., Prescott R.J., Neilson J.M.M., Cowley A.J., Fox K.A.A. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure .The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). European Heart Journal. 20:1999;1335-1341.
7. Cardoso C., Salles G., Bloch K., Deccache W., Siqueira-Filho A.G. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. International Journal of Cardiology. 79:2001;253-262.
8. Christensen P.K., Gall M.A., Major-Pedersen A., Sato A., Rossing P., Breum L., Pietersen A., Kastrup J., Parving H.H. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 60:2000;323-332.
9. Concato J., Feinstein A.R., Holford T.R. The risk of determining risk in multivariate models. Annals of Internal Medicine. 118:1993;201-210.
10. Curb J.D., Rodriguez B.L., Burchfiel C.M., Abbott R.D., Chiu D., Yano K. Sudden death, impaired glucose tolerance and diabetes in Japanese American men. Circulation. 91:1995;2591-2595.
11. Dabrowski A., Kramarz E., Piotrowicz R., Kubik L. Predictive power of increased QT dispersion in ventricular extrasystoles and in sinus beats for risk stratification after myocardial infarction. Circulation. 101:2000;1693-1697.
12. Day C.P., McComb J.M., Campbell R.W.F. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. British Heart Journal. 63:1990;342-344.
13. Day C.P., McComb J.M., Matthews J., Campbell R.W.F. Reduction in QT dispersion by sotalol following myocardial infarction. European Heart Journal. 12:1991;423-427.
14. de Bruyne M.C., Hoes A.W., Kors J.A., Hofman A., van Bemmel J.H., Grobbee D.E. QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam Study. Circulation. 97:1998;467-472.
15. Dekker J.M., Feskens E.J., Schouten E.G., Klootwijk P., Pool J., Kromhout D. QTc duration is associated with levels of insulin and glucose tolerance. The Zutphen Elderly Study. Diabetes. 45:1996;376-380.
16. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Archives of Internal Medicine. 157:1997;1413-1418.
17. Earle K.A., Mishra B., Morocutti A., Barnes D., Chambers J., Viberti G.C. QT dispersion in microalbuminuric type 1 diabetic patients without myocardial ischemia. Journal of Diabetes and its Complications. 14:2000;277-280.
18. Festa A., D'Agostino R. Jr., Rautaharju P., Mykkänen L., Haffner S.M. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. American Journal of Cardiology. 86:2000;1117-1122.
19. Florkowski C.M., Scott R.S., Coope P.A., Moir C.L. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diabetes Research and Clinical Practice. 53:2001;113-120.
20. Ford E.S., DeStefano F. Risk factors for mortality from all-causes and from coronary heart disease among persons with diabetes. American Journal of Epidemiology. 133:1991;1220-1230.
21. Gall M.A., Borch-Johnsen K., Hougaard P., Nielsen F.S., Parving H.H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 44:1995;1303-1309.
22. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine. 339:1998;229-234.
23. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., Nathan D.M., Manson J.E. The impact of diabetes mellitus on mortality from all-causes and coronary heart disease in women. Archives of Internal Medicine. 161:2001;1717-1723.
24. Ko G.T., Chan J.C., Critchley J.A., Cockram C.S. Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval. International Journal of Cardiology. 76:2000;75-80.
25. Kors J.A., van Herpen G., van Bemmel J.H. QT dispersion as an attribute of T-loop morphology. Circulation. 99:1999;1458-1463.
26. Laakso M., Lehto S., Penttilä I., Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 88:1993;1421-1430.
27. Larsen J.A., Kadish A.H. Effects of gender on cardiac arrhythmias. Journal of Cardiovascular Electrophysiology. 9:1998;655-664.
28. Malik M., Batchvarov V.N. Measurement, interpretation and clinical potential of QT dispersion. Journal of the American College of Cardiology. 36:2000;1749-1766.
29. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure, the Framingham study. New England Journal of Medicine. 285:1971;1441-1449.
30. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death: structure, function and time dependence of risk. Circulation. 85(Suppl. I):1992;I2-I10.
31. Naas A.A.O., Davidson N.C., Thompson C., Cummings F., Ogston A.S., Jung R.T., Newton R.W., Struthers A.D. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: cohort study. British Medical Journal. 316:1998;745-746.
32. Niskanen L., Turpeinen A., Penttilä I., Uusitupa M.I.J. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes. Diabetes Care. 21:1998;1861-1869.
33. Oikarinen L., Nieminen M.S., Viitasalo M., Toivonen L., Wachtell K., Papademetriou V., Jern S., Dahlof B., Devereux R.B., Okin P.M. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention for Endpoint Reduction. Journal of Hypertension. 19:2001;1883-1891.
34. Olivarius N.F., Andreasen A.H. Five-year all-cause mortality of 1323 newly diagnosed middle-aged and elderly diabetic patients. Journal of Diabetes and its Complications. 11:1997;83-89.
35. Prineas R.J., Crow R.S., Blackburn H. The Minnesota code manual of electrocardiographic findings, standards and procedures for measurement and classification. 1982;J. Wright, Littleton, MA.
36. Sawicki P.T., Kiwitt S., Bender R., Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. Journal of Internal Medicine. 243:1998;49-56.
37. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. for the Multiple Risk Factor Intervention Trial Research Group Diabetes Care. 16:1993;434-444.
38. Turrini P., Corrado D., Basso C., Nava A., Bauce B., Thiene G. Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation. 103:2001;3075-3080.
39. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
40. Veglio M., Borra M., Stevens L.K., Fuller J.H., Perin P.C. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia. 42:1999;68-75.
41. Vilbergsson S., Sigurdsson G., Sigvaldason H., Sigfusson N. Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavic Study 17-year follow up. Journal of Internal Medicine. 244:1998;309-316.
42. Wei K., Dorian P., Newman D., Langer N. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. Journal of the American College of Cardiology. 26:1995;859-863.
43. Wei M., Gaskill S.P., Haffner S.M., Stern M.P. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. Diabetes Care. 21:1998;1167-1172.
44. Weiderpass E., Gridley G., Nyrén O., Pennello G., Landström A.S., Ekbom A. Cause-specific mortality in a cohort of patients with diabetes mellitus: a population-based study in Sweden. Journal of Clinical Epidemiology. 54:2001;802-809.
45. Whitsel E.A., Boyko E.J., Siscovick D.S. Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes. Diabetes Care. 23:2000;241-247.
46. World Health Organization (1985). Diabetes mellitus. Tech. Rep. Ser. 727, World Health Organization, Geneve.
47. Zabel M., Klingenheben T., Franz M.R., Hohnloser S.H. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction. Results of a prospective, long-term, follow-up study. Circulation. 97:1998;2543-2550.